Veeva Systems (NYSE:VEEV – Get Free Report) had its price target upped by investment analysts at Truist Financial from $262.00 to $305.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Truist Financial’s target price suggests a potential upside of 24.63% from the company’s previous close.
A number of other brokerages have also weighed in on VEEV. TD Cowen restated a “buy” rating on shares of Veeva Systems in a research report on Monday. Wall Street Zen cut Veeva Systems from a “buy” rating to a “hold” rating in a report on Monday, August 3rd. The Goldman Sachs Group dropped their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a report on Thursday, June 4th. Weiss Ratings upgraded shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, August 12th. Finally, Guggenheim boosted their price objective on shares of Veeva Systems from $232.00 to $276.00 and gave the stock a “buy” rating in a research note on Thursday, August 20th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $260.08.
View Our Latest Report on VEEV
Veeva Systems Stock Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $2.22 by $0.13. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. During the same period in the prior year, the company earned $1.99 EPS. Veeva Systems’s revenue for the quarter was up 17.6% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, equities analysts predict that Veeva Systems will post 6.65 EPS for the current fiscal year.
Insider Transactions at Veeva Systems
In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction that occurred on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at approximately $4,866,723.27. This represents a 64.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.
Institutional Investors Weigh In On Veeva Systems
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. SHP Wealth Management bought a new position in shares of Veeva Systems during the 4th quarter worth about $26,000. Compass Financial Management LLC acquired a new stake in Veeva Systems in the second quarter valued at approximately $27,000. Activest Wealth Management increased its holdings in shares of Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after acquiring an additional 127 shares in the last quarter. Arlington Trust Co LLC bought a new position in shares of Veeva Systems in the 2nd quarter worth $29,000. Finally, Field & Main Bank acquired a new stake in Veeva Systems in the 2nd quarter valued at $29,000. 88.20% of the stock is owned by institutional investors.
Trending Headlines about Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva reported fiscal Q2 revenue of $928.0 million, up 17.6% year over year, while EPS of $2.35 exceeded the $2.22 analyst consensus. Subscription revenue increased 16% to $766.8 million. Veeva Announces Fiscal 2027 Second Quarter Results
- Positive Sentiment: Management issued fiscal Q3 revenue guidance of approximately $932 million-$935 million and EPS guidance of $2.33-$2.34, both above Wall Street expectations. Full-year fiscal 2027 EPS guidance of $9.21 and revenue guidance of about $3.7 billion also exceeded consensus estimates. Veeva Q2 2027 Earnings Call Transcript
- Positive Sentiment: Executives highlighted continued strength in Vault CRM, targeting more than 70% market share, and said the first Falcon customer deployments are expected this year. AI-related capabilities are also contributing to demand and revenue growth. Veeva CRM and Falcon Update
- Positive Sentiment: Needham reaffirmed its Buy rating, while Piper Sandler initiated coverage, adding favorable analyst attention following the earnings release. Needham Reaffirms Buy Rating
- Neutral Sentiment: Analyst commentary emphasized Veeva’s combination of recurring growth, strong margins and financial strength, but the stock’s elevated valuation—around 44 times earnings—leaves less room for execution or guidance disappointments.
- Negative Sentiment: The modest decline in the shares despite the earnings and guidance beats suggests investors may be taking profits or were already pricing in strong results. Near-term sentiment could remain sensitive to valuation and the pace of new product adoption.
Veeva Systems Company Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Articles
- Five stocks we like better than Veeva Systems
- NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
- Alphabet Is Building a Base—Could a Breakout Be Next?
- When Unusual Volume Isn’t Noise: 3 Small-Caps Sending Signals
- Is Quantinuum Emerging as a Leader in the Quantum Race?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.jpg){kind=logo}